NCT00287859 arm group 8edac0547a116f20679192f051565be8 [clinicaltrials_resource:NCT00287859/arm-group/8edac0547a116f20679192f051565be8]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00287859 arm group 8edac0547a116f20679192f051565be8 [clinicaltrials_resource:NCT00287859/arm-group/8edac0547a116f20679192f051565be8]
Bio2RDF identifier
NCT00287859/arm-group/8edac0547a116f20679192f051565be8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... dac0547a116f20679192f051565be8
description [clinicaltrials_vocabulary:description]
Patients receive topotecan int ...... ts will be treated at the MTD.
identifier
clinicaltrials_resource:NCT00287859/arm-group/8edac0547a116f20679192f051565be8
title
NCT00287859 arm group 8edac0547a116f20679192f051565be8
@en
type
label
NCT00287859 arm group 8edac054 ...... ac0547a116f20679192f051565be8]
@en